Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Genetics of gastroesophageal cancer: paradigms, paradoxes, and prognostic utility.

Robertson EV, Jankowski JA.

Am J Gastroenterol. 2008 Feb;103(2):443-9. Epub 2007 Oct 9. Review.

PMID:
17925001
2.

Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): the integration of genetic and physical maps of the TOC region on 17q25.

Risk JM, Ruhrberg C, Hennies H, Mills HS, Di Colandrea T, Evans KE, Ellis A, Watt FM, Bishop DT, Spurr NK, Stevens HP, Leigh IM, Reis A, Kelsell DP, Field JK.

Genomics. 1999 Jul 15;59(2):234-42.

PMID:
10409435
3.

Congenital heart disease in tylosis: case report.

Wong ML, Tay JS.

J Singapore Paediatr Soc. 1991;33(1-2):45-8.

PMID:
1784110
4.

[Hereditary tylosis syndrome and esophagus cancer].

de Souza CA, Santos Ada C, Santos Lda C, Carneiro AL.

An Bras Dermatol. 2009 Sep-Oct;84(5):527-9. Portuguese.

5.

Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.

Rygiel AM, Milano F, Ten Kate FJ, Schaap A, Wang KK, Peppelenbosch MP, Bergman JJ, Krishnadath KK.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1380-5. doi: 10.1158/1055-9965.EPI-07-2734.

6.

Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.

Ferguson HR, Wild CP, Anderson LA, Murphy SJ, Johnston BT, Murray LJ, Watson RG, McGuigan J, Reynolds JV, Hardie LJ.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):727-31. doi: 10.1158/1055-9965.EPI-07-2570.

7.

The tylosis esophageal cancer (TOC) locus: more than just a familial cancer gene.

Risk JM, Mills HS, Garde J, Dunn JR, Evans KE, Hollstein M, Field JK.

Dis Esophagus. 1999;12(3):173-6.

PMID:
10631907
8.

[Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].

Mokrowiecka A, Wierzchniewska-Ławska A, Smolarz B, Romanowicz-Makowska H, Malecka-Panas E.

Pol Merkur Lekarski. 2009 May;26(155):385-9. Polish.

PMID:
19606680
9.

Treatment of Barrett's esophagus with high-grade dysplasia.

McAllaster JD, Buckles D, Al-Kasspooles M.

Expert Rev Anticancer Ther. 2009 Mar;9(3):303-16. doi: 10.1586/14737140.9.3.303. Review.

PMID:
19275509
10.

To B or not to B: is tylosis B truly benign? Two North American genealogies.

Maillefer RH, Greydanus MP.

Am J Gastroenterol. 1999 Mar;94(3):829-34.

PMID:
10086674
11.

High risk of malignancy in familial Barrett's esophagus: presentation of one family.

Munitiz V, Parrilla P, Ortiz A, Martinez-de-Haro LF, Yelamos J, Molina J.

J Clin Gastroenterol. 2008 Aug;42(7):806-9. doi: 10.1097/MCG.0b013e3180329015.

PMID:
18385604
12.

Advances in gene chip technique in Barrett's metaplasia and adenocarcinoma.

Wang XW, Gao HJ, Fang DC.

J Dig Dis. 2008 May;9(2):68-71. doi: 10.1111/j.1751-2980.2008.00324.x. Review.

PMID:
18419638
13.

[RHBDF2 mutations in familial palmoplantar keratoderma associated with tylosis oesophageal cancer].

Dereure O.

Ann Dermatol Venereol. 2012 Aug-Sep;139(8-9):605-6. doi: 10.1016/j.annder.2012.04.001. Epub 2012 May 15. French. No abstract available.

PMID:
22963978
14.

Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.

Odze RD, Lauwers GY.

Endoscopy. 2008 Dec;40(12):1008-15. doi: 10.1055/s-0028-1103416. Epub 2008 Dec 8. Review.

PMID:
19065484
15.

Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.

Werther M, Saure C, Pahl R, Schorr F, Rüschoff J, Alles JU, Heinmöller E.

Pathol Res Pract. 2008;204(5):285-94. doi: 10.1016/j.prp.2007.12.011. Epub 2008 Mar 11.

PMID:
18337019
16.

No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.

Ferguson HR, Wild CP, Anderson LA, Murphy SJ, Johnston BT, Murray LJ, Watson RG, McGuigan J, Reynolds JV, Hardie LJ.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):736-9. doi: 10.1158/1055-9965.EPI-07-2832.

17.

Barrett's esophagus in 2008: an update.

Wood RK, Yang YX.

Keio J Med. 2008 Sep;57(3):132-8. Review.

18.

The spectrum of motor function abnormalities in gastroesophageal reflux disease and Barrett's esophagus.

Ang D, Blondeau K, Sifrim D, Tack J.

Digestion. 2009;79(3):158-68. doi: 10.1159/000210265. Epub 2009 Mar 30. Review.

19.

Down-regulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC): evidence for trans-allele repression.

McRonald FE, Liloglou T, Xinarianos G, Hill L, Rowbottom L, Langan JE, Ellis A, Shaw JM, Field JK, Risk JM.

Hum Mol Genet. 2006 Apr 15;15(8):1271-7. Epub 2006 Mar 1.

PMID:
16510494
20.

Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma.

Ochs-Balcom HM, Falk G, Grady WM, Kinnard M, Willis J, Elston R, Eng C, Chak A.

Transl Res. 2007 Jul;150(1):3-17. Epub 2007 May 25. Review.

PMID:
17585859

Supplemental Content

Support Center